In conclusion, the underexpression of LRIG1 and the increase in EGFR/LRIG1 ratios found in RCC compared to the kidney cortex indicate that LRIG1 might be a tumour suppressor that counteracts the tumour-promoting function of EGFR. The gene discussed is EGFR; the disease is neoplasm.